Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy
Status:
Terminated
Trial end date:
2009-02-27
Target enrollment:
Participant gender:
Summary
- feasibility and tolerance of preoperative therapy with Bevacizumab in combination with
Capecitabine and radiotherapy for patients with locally advanced, locally operable
rectal carcinoma
- collection of response rate (T- and M-downstaging, pathological complete remission)